• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人血友病患者的联合出血倾向:不仅仅是药代动力学。

Joint Bleeding Tendencies in Adult Patients With Hemophilia: It's Not All Pharmacokinetics.

机构信息

1 Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, San Diego, CA, USA.

2 Department of Health Evidence, Research Methodology and Impact, McMaster University, Hamilton, Ontario, Canada.

出版信息

Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619862052. doi: 10.1177/1076029619862052.

DOI:10.1177/1076029619862052
PMID:31298044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6714908/
Abstract

Hemophilic arthropathy from joint bleeding remains a complication with major morbidity in the increasingly aging patients with hemophilia. Prophylactic clotting factor infusions, based on pharmacokinetic dosing to reduce bleeding rates, are being explored more and more. However, there is little evidence on the benefits of pharmacokinetic dosing in direct association with bleeding events. Here, we prospectively followed a cohort of adult patients with hemophilia A and B (n = 26) and arthropathic joints on various clotting factor products over a period of 2 years with clinical and radiographic joint health assessments, frequent joint ultrasound, and pharmacokinetic studies. Joint bleeds and synovitis with synovial vascularity changes were objectively diagnosed by musculoskeletal ultrasound and power Doppler and analyzed in relation to pharmacokinetic, joint- and patient-specific parameters. Results revealed that, contrary to common beliefs, bleeding episodes were not readily explained by pharmacokinetic features, as they were not associated with more time spent below certain clotting factor thresholds. Joint bleeding was found to be associated with prominent vascularity changes, suggesting that vascular remodeling and leakiness may contribute to joint bleeding that cannot be prevented by clotting factor replacement alone.

摘要

血友病性关节病是由关节出血引起的并发症,在日益老龄化的血友病患者中发病率较高,致残率较大。目前,越来越多的研究探索基于药代动力学剂量调整以减少出血率的预防性凝血因子输注。然而,关于药代动力学剂量调整与出血事件之间的直接关联的益处的证据很少。在这里,我们前瞻性地随访了一组接受各种凝血因子产品治疗的血友病 A 和 B 成年患者(n=26)和关节病关节,随访时间为 2 年,进行临床和放射学关节健康评估、频繁的关节超声检查和药代动力学研究。通过肌肉骨骼超声和彩色多普勒能量成像客观诊断关节出血和滑膜炎伴滑膜血管变化,并分析药代动力学、关节和患者特定参数与这些变化的关系。结果表明,与普遍观点相反,出血事件不能用药代动力学特征轻易解释,因为它们与在特定凝血因子阈值以下的时间没有关联。关节出血与明显的血管变化有关,提示血管重塑和渗漏可能导致关节出血,单纯的凝血因子替代不能预防这种出血。

相似文献

1
Joint Bleeding Tendencies in Adult Patients With Hemophilia: It's Not All Pharmacokinetics.成人血友病患者的联合出血倾向:不仅仅是药代动力学。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619862052. doi: 10.1177/1076029619862052.
2
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.凝血因子浓缩物用于预防甲型或乙型血友病患者的出血及与出血相关的并发症。
Cochrane Database Syst Rev. 2005 Apr 18(2):CD003429. doi: 10.1002/14651858.CD003429.pub2.
3
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.凝血因子浓缩物用于预防甲型或乙型血友病患者的出血及与出血相关的并发症。
Cochrane Database Syst Rev. 2006 Apr 19(2):CD003429. doi: 10.1002/14651858.CD003429.pub3.
4
Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.凝血因子浓缩物用于预防甲型或乙型血友病患者的出血及与出血相关的并发症。
Cochrane Database Syst Rev. 2011 Sep 7(9):CD003429. doi: 10.1002/14651858.CD003429.pub4.
5
Persistent Vascular Remodeling and Leakiness are Important Components of the Pathobiology of Re-bleeding in Hemophilic Joints: Two Informative Cases.持续性血管重塑和渗漏是血友病性关节再出血病理生物学的重要组成部分:两例资料丰富的病例。
Microcirculation. 2016 Jul;23(5):373-8. doi: 10.1111/micc.12273.
6
Hemophilic arthropathy of the elbow: prophylaxis, imaging, and the role of invasive management.肘部血友病性关节病:预防、影像学及侵入性治疗的作用
J Shoulder Elbow Surg. 2015 Oct;24(10):1669-78. doi: 10.1016/j.jse.2015.06.018.
7
[Conservative management of hemophilic arthropathy].[血友病性关节病的保守治疗]
Orthopade. 1999 Apr;28(4):347-55. doi: 10.1007/s001320050357.
8
EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice.EPCR 缺乏或功能阻断抗体可预防血友病小鼠关节出血引起的病变。
Blood. 2020 Jun 18;135(25):2211-2223. doi: 10.1182/blood.2019003824.
9
Total knee arthroplasty in hemophilic arthropathy: efficiency of clotting factor usage in multijoint procedures.血友病性关节病的全膝关节置换术:多关节手术中凝血因子的使用效率
J Thromb Haemost. 2009 Oct;7(10):1741-3. doi: 10.1111/j.1538-7836.2009.03569.x. Epub 2009 Aug 11.
10
Point-of-care musculoskeletal ultrasound is critical for the diagnosis of hemarthroses, inflammation and soft tissue abnormalities in adult patients with painful haemophilic arthropathy.即时肌肉骨骼超声对于诊断成年血友病性关节病疼痛患者的关节积血、炎症及软组织异常至关重要。
Haemophilia. 2015 Jul;21(4):530-7. doi: 10.1111/hae.12637. Epub 2015 Jan 27.

引用本文的文献

1
Synovial Gene expression after Hemarthrosis differs between FVIII-deficient mice treated with recombinant FVIII or FVIII-Fc Fusion Protein.关节积血后,接受重组FVIII或FVIII-Fc融合蛋白治疗的FVIII缺陷小鼠的滑膜基因表达存在差异。
PLoS One. 2025 May 19;20(5):e0320322. doi: 10.1371/journal.pone.0320322. eCollection 2025.
2
AAV mediated repression of Neat1 lncRNA combined with F8 gene augmentation mitigates pathological mediators of joint disease in haemophilia.AAV 介导的 Neat1 lncRNA 抑制与 F8 基因增强联合减轻血友病性关节病的病理介质。
J Cell Mol Med. 2024 Jun;28(11):e18460. doi: 10.1111/jcmm.18460.
3
Pharmacokinetic-Pharmacodynamic Modelling in Hemophilia A: Relating Thrombin and Plasmin Generation to Factor VIII Activity After Administration of a VWF/FVIII Concentrate.

本文引用的文献

1
Recombinant factor VIII Fc fusion protein drives regulatory macrophage polarization.重组因子 VIII Fc 融合蛋白驱动调节性巨噬细胞极化。
Blood Adv. 2018 Nov 13;2(21):2904-2916. doi: 10.1182/bloodadvances.2018024497.
2
Development and Reliability of the Joint Tissue Activity and Damage Examination for Quantitation of Structural Abnormalities by Musculoskeletal Ultrasound in Hemophilic Joints.血友病性关节的肌肉骨骼超声定量结构异常的关节组织活动和损伤检测的开发和可靠性。
J Ultrasound Med. 2019 Jun;38(6):1569-1581. doi: 10.1002/jum.14846. Epub 2018 Oct 29.
3
Improvement in clinical outcomes and replacement factor VIII use in patients with haemophilia A after factor VIII pharmacokinetic-guided prophylaxis based on Bayesian models with myPKFiT.
血友病 A 的药代动力学-药效学建模:在给予 vWF/FVIII 浓缩物后,将凝血酶和纤溶酶生成与因子 VIII 活性相关联。
Eur J Drug Metab Pharmacokinet. 2024 Mar;49(2):191-205. doi: 10.1007/s13318-024-00876-6. Epub 2024 Feb 17.
4
Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A.预防轻度 A 型血友病关节出血的最小 VIII 因子水平。
Blood Adv. 2023 Dec 12;7(23):7209-7215. doi: 10.1182/bloodadvances.2023011366.
5
Exploration of the minimum necessary FVIII level at different physical activity levels in pediatric patients with hemophilia A.探索甲型血友病患儿在不同体力活动水平下的最低所需FVIII水平。
Front Pediatr. 2022 Nov 1;10:1045070. doi: 10.3389/fped.2022.1045070. eCollection 2022.
6
How do we optimally utilize factor concentrates in persons with hemophilia?我们应如何优化利用因子浓缩物治疗血友病患者?
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):206-214. doi: 10.1182/hematology.2021000310.
7
A semiquantitative color Doppler ultrasound scoring system for evaluation of synovitis in joints of patients with blood-induced arthropathy.一种用于评估血液性关节病患者关节滑膜炎的半定量彩色多普勒超声评分系统。
Insights Imaging. 2021 Sep 25;12(1):132. doi: 10.1186/s13244-021-01043-0.
8
Asymptomatic Joint Bleeding and Joint Health in Hemophilia: A Review of Variables, Methods, and Biomarkers.血友病中的无症状关节出血与关节健康:变量、方法及生物标志物综述
J Blood Med. 2021 Apr 1;12:209-220. doi: 10.2147/JBM.S304597. eCollection 2021.
9
Emerging benefits of Fc fusion technology in the context of recombinant factor VIII replacement therapy.Fc 融合技术在重组凝血因子 VIII 替代治疗中的新获益。
Haemophilia. 2020 Nov;26(6):958-965. doi: 10.1111/hae.14123. Epub 2020 Sep 3.
基于贝叶斯模型的 myPKFiT 的因子 VIII 药代动力学指导预防后,A型血友病患者的临床结局改善和因子 VIII 使用的替代。
Haemophilia. 2018 Sep;24(5):e338-e343. doi: 10.1111/hae.13540. Epub 2018 Jul 20.
4
Vascular Permeability and Remodelling Coincide with Inflammatory and Reparative Processes after Joint Bleeding in Factor VIII-Deficient Mice.血管通透性和重塑与因子 VIII 缺乏症小鼠关节出血后的炎症和修复过程同时发生。
Thromb Haemost. 2018 Jun;118(6):1036-1047. doi: 10.1055/s-0038-1641755. Epub 2018 May 30.
5
Tolerogenic properties of the Fc portion of IgG and its relevance to the treatment and management of hemophilia.IgG Fc 段的免疫耐受特性及其与血友病治疗和管理的相关性。
Blood. 2018 May 17;131(20):2205-2214. doi: 10.1182/blood-2017-12-822908. Epub 2018 Mar 27.
6
Use of ultrasound for evaluation of painful joint episodes perceived as haemarthrosis in adult patients with severe haemophilia.超声在评估重度血友病成年患者中被视为关节积血的疼痛性关节发作方面的应用。
Haemophilia. 2018 May;24(3):e124-e125. doi: 10.1111/hae.13439. Epub 2018 Mar 1.
7
Musculoskeletal ultrasound for intra-articular bleed detection: a highly sensitive imaging modality compared with conventional magnetic resonance imaging.肌肉骨骼超声在关节内出血检测中的应用:与常规磁共振成像相比,具有更高的敏感性。
J Thromb Haemost. 2018 Mar;16(3):490-499. doi: 10.1111/jth.13930. Epub 2018 Jan 19.
8
Improved joint health in subjects with severe haemophilia A treated prophylactically with recombinant factor VIII Fc fusion protein.预防性使用重组凝血因子 VIII Fc 融合蛋白治疗重型 A 型血友病患者的关节健康改善。
Haemophilia. 2018 Jan;24(1):77-84. doi: 10.1111/hae.13353. Epub 2017 Oct 30.
9
Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforcePart 1: definition and development of a standardised, consensus-based scoring system.类风湿关节炎中超声滑膜炎评分:欧洲抗风湿病联盟-国际骨关节炎研究学会超声特别工作组 第1部分:基于共识的标准化评分系统的定义与制定
RMD Open. 2017 Jul 11;3(1):e000428. doi: 10.1136/rmdopen-2016-000428. eCollection 2017.
10
Monitoring joint health in haemophilia: Factors associated with deterioration.监测血友病患者的关节健康:与病情恶化相关的因素。
Haemophilia. 2017 Nov;23(6):934-940. doi: 10.1111/hae.13327. Epub 2017 Sep 5.